WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+32.21%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$2.52B
AUM Growth
+$1.12B
(+80%)
Cap. Flow
+$852M
Cap. Flow
% of AUM
33.74%
Top 10 Holdings %
Top 10 Hldgs %
26.22%
Holding
205
New
69
Increased
52
Reduced
26
Closed
58
Top Buys
| 1 |
Intel
INTC
|
$62.5M |
| 2 |
Johnson & Johnson
JNJ
|
$58.9M |
| 3 |
Fidelity National Information Services
FIS
|
$55.3M |
| 4 |
PayPal
PYPL
|
$52M |
| 5 |
KLA
KLAC
|
$50.2M |
Top Sells
| 1 |
Pfizer
PFE
|
$65.7M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$50M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$46.8M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$46.5M |
| 5 |
Analog Devices
ADI
|
$25.9M |
Sector Composition
| 1 | Healthcare | 46.91% |
| 2 | Technology | 35.52% |
| 3 | Communication Services | 5.66% |
| 4 | Consumer Discretionary | 4.26% |
| 5 | Industrials | 2.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Exact Sciences
EXAS
$10.2B
| $3.08M | 0.12% |
+35,432
| New | +$3.08M |
|
127
Cinemark Holdings
CNK
$2.98B
| $3.06M | 0.12% |
264,597
-123,246
| -32% | -$1.42M |
|
128
Acadia Pharmaceuticals
ACAD
$4.26B
| $2.99M | 0.12% |
+61,575
| New | +$2.99M |
|
129
Warner Music
WMG
$17B
| $2.95M | 0.12% |
+100,000
| New | +$2.95M |
|
|
MNTA
130
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $2.79M | 0.11% |
83,947
-114,920
| -58% | -$3.82M |
|
|
AFMD
131
DELISTED
Affimed
AFMD
| $2.68M | 0.11% |
57,960
+10,756
| +23% | +$496K |
|
|
CHMA
132
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $2.26M | 0.09% |
419,736
-149,608
| -26% | -$805K |
|
133
Zentalis Pharmaceuticals
ZNTL
$126M
| $2.1M | 0.08% |
+43,726
| New | +$2.1M |
|
|
FUSN
134
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $2.1M | 0.08% |
+120,000
| New | +$2.1M |
|
135
Bruker
BRKR
$4.68B
| $1.86M | 0.07% |
+45,647
| New | +$1.86M |
|
|
ORTX
136
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $1.75M | 0.07% |
29,225
-29,900
| -51% | -$1.79M |
|
137
Maximus
MMS
$4.97B
| $1.44M | 0.06% |
+20,403
| New | +$1.44M |
|
138
Envista
NVST
$3.54B
| $1.06M | 0.04% |
+50,115
| New | +$1.06M |
|
139
Savara
SVRA
$643M
| $917K | 0.04% |
368,420
+19,474
| +6% | +$48.5K |
|
140
Cencora
COR
$56.7B
| $890K | 0.04% |
8,830
-137,177
| -94% | -$13.8M |
|
|
API
141
Agora
API
$310M
| $729K | 0.03% |
+16,495
| New | +$729K |
|
142
Vaxcyte
PCVX
$4.29B
| $728K | 0.03% |
+23,026
| New | +$728K |
|
|
NARI
143
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $650K | 0.03% |
+13,409
| New | +$650K |
|
|
PRAH
144
DELISTED
PRA Health Sciences, Inc.
PRAH
| $543K | 0.02% |
+5,582
| New | +$543K |
|
|
INFN
145
DELISTED
Infinera Corporation Common Stock
INFN
| $521K | 0.02% |
88,054
-179,910
| -67% | -$1.06M |
|
146
HealthEquity
HQY
$7.88B
| $358K | 0.01% |
+6,100
| New | +$358K |
|
|
AMTI
147
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $276K | 0.01% |
+10,993
| New | +$276K |
|
148
BioMarin Pharmaceuticals
BMRN
$11.1B
| – | – |
-134,149
| Closed | -$11.3M |
|
149
Apple
AAPL
$3.56T
| – | – |
-216,108
| Closed | -$13.7M |
|
150
Abbott
ABT
$231B
| – | – |
-120,616
| Closed | -$9.52M |
|